A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
for Pancreatic Ductal Adenocarcinoma (PDAC)
16 locations incl. Los Angeles
Sponsor: Verastem, Inc.
Sex: All·Age: 18+
Code: NCT07644559·Phase 2·Recruiting·Listed Jun 12, 2026